1. Parexel International Corporation
2. Pharmaceutical Product Development (PPD)
3. Charles River Laboratory
4. ICON plc
5. SGS SA
6. Eli Lilly and Company
7. Pfizer Inc.
8. Covance Inc.
9. Novo Nordisk
10. Rebus Bio
Published | Pages | Publisher | Report code |
---|---|---|---|
Nov 2023 | 171 | TechSci Research | ASDR-640739 |
1. Parexel International Corporation
2. Pharmaceutical Product Development (PPD)
3. Charles River Laboratory
4. ICON plc
5. SGS SA
6. Eli Lilly and Company
7. Pfizer Inc.
8. Covance Inc.
9. Novo Nordisk
10. Rebus Bio